Clinical trial
Combination of Azacitadine and Hematopoietic Growth Factors for Myelodysplastic Syndrome
NCT00398047 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Combination of Azacitadine and Hematopoietic Growth Factors for Myelodysplastic Syndrome
- Lead sponsor
- Wake Forest University Health Sciences
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- September 30, 2006
- Completion date
- September 30, 2009
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.